These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 377493)

  • 21. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets.
    Mastacchi R; Barbanti M; Bianchini P; Osima B
    Agents Actions; 1986 Mar; 17(5-6):512-4. PubMed ID: 3518359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of platelet aggregation and elevation of cyclic-AMP levels in platelets by 13,14-dehydro PGI2 methyl ester.
    Malmsten C; Claesson HE; Fried J
    Prostaglandins Med; 1980 Jun; 4(6):453-63. PubMed ID: 6251494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of PGI2 on platelet aggregation induced by various stimulants.
    Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet involvement in the activated coagulation time of heparinized blood.
    Moorehead MT; Westengard JC; Bull BS
    Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
    J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.
    Jaschonek K; Faul C; Daiss W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Oct; 24(2-3):199-206. PubMed ID: 2432618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
    Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
    Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB; Miller OV; Spillers C; Gorman RR
    Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of interaction of heparin with ADP and prostacyclin on rat platelets.
    Roncaglioni MC; Bertelé V; de Gaetano G; Donati MB
    Thromb Res; 1983 Jul; 31(2):397-400. PubMed ID: 6356460
    [No Abstract]   [Full Text] [Related]  

  • 33. Interactions between prostacyclin analogue ZK 36374 and heparin in their effects upon platelet function.
    Yardumian DA; O'Flynn K; Linch DC; Machin SJ
    Br J Haematol; 1987 Mar; 65(3):325-30. PubMed ID: 2436647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of adenosine diphosphate-induced intravascular aggregation of rat platelets in vivo by 6-oxo-prostaglandin E1.
    Oyekan AO; Botting JH
    Prostaglandins; 1987 Sep; 34(3):359-66. PubMed ID: 3324168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influences of prostaglandins on electrophoretic mobility and aggregation of rabbit platelets.
    Takano S; Itagaki S; Sakurai K; Suzuki T
    Prostaglandins; 1980 Sep; 20(3):579-86. PubMed ID: 6999547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of age, sex, and the use of oral contraceptives on the inhibitory effects of endothelial cells and PGI2 (prostacyclin) on platelet function.
    Nordøy A; Svensson B; Haycraft D; Hoak JC; Wiebe D
    Scand J Haematol; 1978 Sep; 21(3):177-87. PubMed ID: 362511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of platelet factor 3 availability by prostacyclin.
    Hársfalvi J; Muszbek L; Stadler I; Fésüs L
    Prostaglandins; 1980 Nov; 20(5):935-45. PubMed ID: 7008092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostacyclin and blood coagulation.
    Moncada S; Vane JR
    Drugs; 1981 Jun; 21(6):430-7. PubMed ID: 7018874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelets of spontaneously hypertensive rats are not abnormally sensitive to PGI2.
    Botha JH; Leary WP
    Prostaglandins Med; 1981 Dec; 7(6):499-500. PubMed ID: 7034022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.